DiagnoCure (DGCRF) Stock Statistics & Valuation Metrics

DiagnoCure has a market cap or net worth of $43.00. The enterprise value is ―.

DiagnoCure has 43,040,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

DiagnoCure’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, DiagnoCure had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was -1.08M and capital expenditures -10.64K, giving a free cash flow of -1.09M billion.

DiagnoCure pays an annual dividend of $0.091, resulting in a dividend yield of ―

DiagnoCure upcoming earnings date is ―, ―.

DiagnoCure as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, DiagnoCure has paid ― in taxes.

DiagnoCure EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

DiagnoCure has $392.49K in cash and marketable securities with C$0.00 in debt, giving a net cash position of -$392.49K billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for DiagnoCure is ―, which is 11.43% higher than the current price. The consensus rating is ―